Attenuation of hyperlipidemia by medicinal formulations of emblica officinalis synergized with nanotechnological approaches

HIGHLIGHTS

  • who: Puttasiddaiah Rachitha et al. from the PGDepartment of Biotechnology, Teresian College, Siddarthanagar, Mysuru, India Department of Food Science, Fu Jen Catholic University, New Taipei City , Taiwan have published the article: Attenuation of Hyperlipidemia by Medicinal Formulations of Emblica officinalis Synergized with Nanotechnological Approaches, in the Journal: Bioengineering 2023, 64 of 15/Nov/2022
  • what: The current review provides a summary of the phytoconstituents of E. pharmacological actions detailing the plant E. officinalis`s traditional uses and especially hyperlipidemic activity. Correspondingly the Article describes the uses of nanotechnology in amla therapeutics and functional ingredients. The . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?